Larvol Delta - Biotheryx-Announces-US-FDA-Clearance-of-Investigational-New-Drug-Application-for-BTX9341-a-FirstInClass-Dual-Bifunctional-Degrader-of-CDK46

BTX-9341 - BioTheryX

https://www.prnewswire.com/news-releases/biotheryx-announces-us-fda-clearance-of-investigational-new-drug-application-for-btx-9341-a-first-in-class-dual-bifunctional-degrader-of-cdk46-302137704.html

May 7, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next